Relay Therapeutics, Inc.
RLAY- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001812364
In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Relay Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 200 | 4 | 208 | +12 |
| Shares | 163.9M | 4.69M | 167.3M | +8.03M (+5.0%) |
| Value | $675.8M | $19.3M | $438.1M | −$218.3M (−33.3%) |
4 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Relay Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (24)
Institutions that held Relay Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $5.77M |
| Exome Asset Management LLC | 1,083,487 | $4.46M |
| Boxer Capital Management, LLC | 536,132 | $2.21M |
| Cubist Systematic Strategies, LLC | 317,211 | $1.31M |
| BIT Capital GmbH | 284,508 | $1.17M |
| Jump Financial, LLC | 138,226 | $569.5K |
| First Trust Advisors LP | 89,949 | $370.6K |
| Qube Research & Technologies Ltd | 87,863 | $362.0K |
| Nebula Research & Development LLC | 86,641 | $357.0K |
| Aristides Capital LLC | 43,400 | $178.8K |
| Graham Capital Management, L.P. | 31,569 | $130.1K |
| Savant Capital, LLC | 29,088 | $119.8K |
| Marshall Wace, LLP | 27,768 | $114.4K |
| Syon Capital LLC | 22,157 | $91.3K |
| Virtu Financial LLC | 15,046 | $62.0K |
| Virtus ETF Advisers LLC | 14,873 | $61.3K |
| Atom Investors LP | 11,765 | $48.5K |
| Twinbeech Capital LP | 10,204 | $42.0K |
| Stifel Financial Corp | 10,200 | $42.0K |
| Wingate Wealth Advisors, Inc. | 5,000 | $20.6K |
| Group One Trading, L.P. | 4,774 | $19.7K |
| R Squared Ltd | 1,180 | $4.86K |
| Ancora Advisors, LLC | 110 | $453 |
| WealthTrak Capital Management LLC | 30 | $124 |
Not filed for Q1 2025 yet (4)
Institutions that held Relay Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nextech Invest AG | 3,846,409 | $15.8M |
| Nuveen Asset Management, LLC | 653,428 | $2.69M |
| Fernwood Investment Management, LLC | 185,763 | $765.3K |
| Global Retirement Partners, LLC | 562 | $2.31K |